How does Invesco Ltd. (IVZ) change from a tortoise to a hare?

Invesco Ltd. (NYSE: IVZ) stock jumped 1.31% on Thursday to $15.51 against a previous-day closing price of $15.31. With 3.89 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.86 million shares. During the session, the Asset Management company that operates in wider Financial sector, reached to the highest price of $15.59 whereas the lowest price it dropped to was $15.31. The 52-week range on IVZ shows that it touched its highest point at $20.56 and its lowest point at $13.20 during that stretch. It currently has a 1-year price target of $17.79. With its current market cap of 6.91 billion, IVZ has annualized dividend of $0.80 while the current yield stands at 5.16%. Beta for the stock currently stands at 1.40.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IVZ was up-trending over the past week, with a rise of 1.11%, but this was down by -0.45% over a month. Three-month performance dropped to -6.34% while six-month performance fell -3.18%. The stock lost -6.11% in the past year, while it has lost -13.79% so far this year. A look at the trailing 12-month EPS for IVZ yields 1.40 with Next year EPS estimates of 1.88. For the next quarter, that number is 0.39. This implies an EPS growth rate of -50.30% for this year and 19.00% for next year. EPS is expected to grow by 14.90% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -9.30%.

Float and Shares Shorts:

At present, 457.90 million IVZ shares are outstanding with a float of 359.63 million shares on hand for trading. On Aug 30, 2023, short shares totaled 10.84 million, which was 2.42% higher than short shares on Jul 30, 2023. In addition to Mr. Andrew Ryan Schlossberg as the firm’s Pres, CEO & Director, Ms. Laura Allison Dukes serves as its Sr. MD & CFO.

Institutional Ownership:

Through their ownership of 89.13% of IVZ’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 46.36% of IVZ, in contrast to 39.23% held by mutual funds. Shares owned by individuals account for 30.48%. As the largest shareholder in IVZ with 17.75% of the stake, Massachusetts Mutual Life Insuran holds 81,332,319 shares worth 81,332,319. A second-largest stockholder of IVZ, The Vanguard Group, Inc., holds 51,807,960 shares, controlling over 11.31% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in IVZ, holding 35,376,522 shares or 7.72% stake. With a 3.01% stake in IVZ, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 13,787,620 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.53% of IVZ stock, is the second-largest Mutual Fund holder. It holds 11,602,957 shares valued at 194.93 million. iShares Tr. – Select Dividend ETF holds 2.42% of the stake in IVZ, owning 11,097,111 shares worth 186.43 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, IVZ reported revenue of $1.53B and operating income of $344.90M. The EBITDA in the recently reported quarter was $322.70M and diluted EPS was $0.26.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IVZ since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With IVZ analysts setting a high price target of $21.00 and a low target of $16.00, the average target price over the next 12 months is $17.75. Based on these targets, IVZ could surge 35.4% to reach the target high and rise by 3.16% to reach the target low. Reaching the average price target will result in a growth of 14.44% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded IVZ stock several times over the past three months with 6 Buys and 0 Sells. In these transactions, 642,564 shares were bought while 0 shares were sold. The number of buy transactions has increased to 39 while that of sell transactions has risen to 20 over the past year. The total number of shares bought during that period was 2,056,556 while 8,753,737 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *